- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02162654
Remote Ischemic Preconditioning for Intracranial Aneurysm Treatment (RIPAT)
The Role of Remote Ischemic Preconditioning in the Prevention of Ischemic Brain Damage During Intracranial Aneurysm Treatment (RIPAT) - A Prospective Randomized Exploratory Study
연구 개요
상세 설명
Prospective, randomized, double-blind, explorative single center clinical trial in patients subjected to the treatment of an un-ruptured intracranial aneurysm, either by surgical clipping or endovascular coiling. Goal of the study is to determine whether remote ischemic preconditioning (RIPC) prior to aneurysm treatment alters various biomarkers associated with ischemic central neuronal tissue damage. The trial takes place at Innsbruck University Hospital of Innsbruck Medical University, Innsbruck, Austria.
Patients fulfilling inclusion criteria are randomly allocated either to pre-interventional ischemic preconditioning (Group A = intervention group) or sham preconditioning (Group B = control group). RIPC is performed by inflating a blood pressure cuff around one upper extremity three times for five minutes with five minutes interval with the patient under general anesthesia prior to the start of the procedure.
Patients, all staff involved in diagnosis and treatment and all study members are blinded to the patients' group affiliation. The anesthesiologist and two staff members who perform preconditioning are not blinded.
Primary outcome is a difference of ± 2SD in the concentration-time curve of a panel of biochemical parameters indicative of cerebral ischemia (S100B, NSE, GFAP, MMP9, MBP, microparticles) in the first five days after the intervention. Secondary outcome parameters are changes in the post-interventional MRI and neuropsychological and clinical outcome at six and 12 months.
CONSORT and TIDieR guidelines will be followed. The trail will be registered in a public database. The trail protocol will be published in an open-access journal.
연구 유형
등록 (예상)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Innsbruck, 오스트리아, 6020
- 모병
- Clinical Department of Neurosurgery, Innsbruck Medical University
-
연락하다:
- Martin Ortler, M.D., MSc.
- 전화번호: 80975 0043-512-504
- 이메일: martin.ortler@i-med.ac.at
-
연락하다:
- Selma Tülü, Cand. med.
- 이메일: selma.tuelue@student.i-med.ac.at
-
수석 연구원:
- Martin Ortler, MD, MSc
-
부수사관:
- Claudius Thomé, M.D.
-
부수사관:
- Selma Tülü, Cand.med.
-
부수사관:
- Miriam Mulino, M.D.
-
부수사관:
- Daniel Pinggera, M.D.
-
부수사관:
- Claudia Unterhofer, M.D.
-
부수사관:
- Erich Schmutzhard, M.D.
-
부수사관:
- Bettina Pfausler, M.D.
-
부수사관:
- Ronny Beer, M.D.
-
부수사관:
- Raimund Helbok, M.D.
-
부수사관:
- Peter Lackner, M.D.
-
부수사관:
- Thomas Benke, M.D.
-
부수사관:
- Thomas Bodner, M.D.
-
부수사관:
- Margarethe Delazer, M.D.
-
부수사관:
- Raffaella Matteucci-Gothe, Ph.D.
-
부수사관:
- Uwe Siewert, Ph.D.
-
부수사관:
- Philipp Würtinger, M.D.
-
부수사관:
- Andrea Griesmacher, M.D.
-
부수사관:
- Markus Luger, M.D.
-
부수사관:
- Arnulf Benzer, M.D.
-
부수사관:
- Franz Wiedermann, M.D.
-
부수사관:
- Astrid Grams, M.D.
-
부수사관:
- Elke Gizewski, M.D.
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Informed written consent of patient
- Age > 18 years
- Intracranial aneurysm, single or multiple, intervention as indicated by interdisciplinary vascular board (includes previously treated aneurysms)
- Normal baseline MRI
Exclusion Criteria:
- Clinical or radiological signs of subarachnoid hemorrhage
- Planned vessel sacrifice as the primary modality for aneurysm treatment
- Dissecting or mycotic aneurysm
- Previous history of stroke or TIA within the last six months
- Signs or symptoms of upper and lower extremity peripheral vascular illness
- Drugs and lifestyle factors that interfere with biomarker Determination
- Inability to complete neuropsychological testing for language reasons
- Patients unable to have an MRI scan for any reason
- Previous serious cerebral disease that would preclude completion of the protocol or preclude MRI analysis of small strokes
- Pregnancy
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: Remote ischemic preconditioning
Inflation of a blood pressure cuff around an arm with the patient under general anesthesia prior to start aneurysm treatment
|
The blood pressure cuff is inflated to 200 mmHg for 3 x 5 minutes with 5 minutes of reperfusion by complete cuff deflation each.
|
|
가짜 비교기: Sham preconditioning
Sham inflation of a blood pressure cuff around an arm with the patient under general anesthesia prior to start aneurysm treatment
|
The blood pressure cuff is inflated to 10 mmHg for 3 x 5 minutes with 5 minutes of complete cuff deflation each.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Area-under-Curve for biomarkers in the first 5 days after aneurysm treatment(S100B, NSE, GFAP, NSE, MMP9, Microparticles)
기간: on admission, after preconditioning but prior to intervention, at completion of intervention, at hours 3, 6, 12, 24, 48, 72, 96, 120 after completion of intervention
|
Serum biomarkers reflect brain tissue ischemic damage with various specificity and sensitivity (see Whiteley 2008, Ahmad 2012) Advantages include (1) to be available early, (2) to be continuous variables (low study n), (3) they were able to demonstrate an effect of ischemic preconditioning in other clinical studies (see Koch 2010, Veighei 2012)
|
on admission, after preconditioning but prior to intervention, at completion of intervention, at hours 3, 6, 12, 24, 48, 72, 96, 120 after completion of intervention
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Number (n) of new lesions in postinterventional MRI (DWI and FLAIR)
기간: preinterventional/on day 1 or 2
|
Outcome Parameter used in other clinical studies focussing on ischemia after neurointerventional procedures (e.g.
ENACT study)
|
preinterventional/on day 1 or 2
|
|
Clinical outcome ( National Institutes of Health Stroke Scale, NIHSS and modified Rankin Scale mRS)
기간: at discharge, at 6 and 12 months
|
Established outcome parameters for cerebrovascular studies.
Dichotomized into favourable (NIHSS ≤1, mRS 0-1) and unfavourable
|
at discharge, at 6 and 12 months
|
|
Volume (mm3) of new lesions in postinterventional MRI (DWI and FLAIR)
기간: preinterventional, postinterventional on day 1 or 2
|
As above for number of lesions
|
preinterventional, postinterventional on day 1 or 2
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Neuropsychological testing VLMTA (Verbaler Lern- und Merkfähigkeitstest), the WMS-R (Zahlenspanne vorwärts und rückwärts), trail making A and B tests, the Regensburger Wortflüssigkeitstest, the TAP Wechsel verbal, the TAP and the HADS-D)
기간: preinterventional, at 6 and 12 months
|
Standard tests used in patients with cerebrovascular disorders in our departments.
Not applicable to non-german-speaking patients.
|
preinterventional, at 6 and 12 months
|
|
Brain volume changes (MRI, voxel -based morphometry)
기간: Preinterventional/at the 12 months FU
|
Longterm brain volume changes that correlate with NP deficits (Horstmann 2010, Moskowitz 2011, Vuylsteke 2011) will be analyzed using voxel-based morphometry techniques
|
Preinterventional/at the 12 months FU
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Martin Ortler, M.D., MSc., Clinical Department of Neurosurgery, Innsbruck Medical University
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .